SciQuest (NASDAQ: SQI) and Paylocity (NASDAQ:PCTY) are both software – nec companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Earnings and Valuation

This table compares SciQuest and Paylocity’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SciQuest N/A N/A N/A $0.11 161.36
Paylocity $300.01 million 8.14 $6.71 million $0.18 258.28

Paylocity has higher revenue and earnings than SciQuest. SciQuest is trading at a lower price-to-earnings ratio than Paylocity, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and price targets for SciQuest and Paylocity, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SciQuest 0 0 0 0 N/A
Paylocity 0 5 9 0 2.64

Paylocity has a consensus target price of $52.92, indicating a potential upside of 13.82%. Given Paylocity’s higher probable upside, analysts clearly believe Paylocity is more favorable than SciQuest.

Risk & Volatility

SciQuest has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Paylocity has a beta of 2.11, meaning that its stock price is 111% more volatile than the S&P 500.

Profitability

This table compares SciQuest and Paylocity’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SciQuest 3.93% 2.23% 1.59%
Paylocity 3.11% 7.98% 0.93%

Insider & Institutional Ownership

59.8% of Paylocity shares are owned by institutional investors. 48.8% of Paylocity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Paylocity beats SciQuest on 9 of the 11 factors compared between the two stocks.

About SciQuest

SciQuest, Inc. is a United States-based public provider of spend management solutions. The Company’s offers a range of solutions, such as Spend Director, Spend Radar, Sourcing Director, Advanced Sourcing Optimizer, Total Contract Manager, Total Supplier Manager, Enterprise Reagent Manager, Accounts Payable Director, Supplier Network and Portfolio Savings Manager. Its Spend Director is an e-procurement software, which allows users’ to integrate and automate processes, suppliers, compliance and workflows. Its Portfolio Savings Manager is a cloud-based savings management software that integrates project forecasting, initiative approval workflows and real-time savings. Its chemical inventory management software, Enterprise Reagent Manager (ERM), allows scientific staff in the organization to find, source and track commercial and proprietary chemicals, reagents and lab supplies. Its Total Contract Manager is a Contract Lifecycle Management solution that offers real-time updates.

About Paylocity

Paylocity Holding Corporation is a cloud-based provider of payroll and human capital management (HCM), software solutions for medium-sized organizations. The Company’s services are provided in a software-as-a-service delivery model utilizing its cloud-based platform. The cloud-based platform provides a suite of applications using a multi-tenant architecture. The cloud-based platform features a suite of unified payroll and HCM applications. The Company, through cloud-based platform, offers various products, which include Paylocity Web Pay, Paylocity HR, Paylocity Affordable Care Act Enhanced, Paylocity Impressions, Performance Management, Self-Service HR Portals, Paylocity Recruiting, Paylocity Web Time, Paylocity Web Onboarding, and Paylocity Web Benefits and Paylocity Enterprise Benefits, Powered by bswift. The multi-tenant software platform is configurable and includes a unified suite of payroll and HCM applications, such as time and labor tracking, benefits and talent management.

Receive News & Ratings for SciQuest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciQuest and related companies with Analyst Ratings Network's FREE daily email newsletter.